Story
Centene Boosts Full-Year Profit Forecast on Tighter Cost Controls
Summary
The health insurer raised its annual profit and revenue guidance after its second-quarter medical loss ratio came in significantly better than expected, signaling improved cost management.
Health insurer Centene on Tuesday raised its full-year profit and revenue forecasts after reporting second-quarter earnings that significantly surpassed analyst estimates, driven by better-than-expected cost controls. The company's shares rose 2% in pre-market trading following the announcement.
Upgraded Financial Outlook
Centene provided an upgraded financial outlook for the full year, citing a strong performance in the second quarter. The company announced its quarterly adjusted profit was $2.51 per share, well ahead of the $1.09 per share anticipated by analysts, according to LSEG data.
Based on these results, the company updated its guidance:
- Adjusted Profit: Forecast raised to more than $4.80 per share, up from a previous forecast of above $3.40 per share. Analysts had been expecting $3.52.
- Full-Year Revenue: Now projected to be between $193.5 billion and $197.5 billion, an increase from the prior range of $187.5 billion to $191.5 billion.
"Our second-quarter results and improved full-year outlook represent meaningful milestones on our path to restoring profitability and increasing shareholder value," CEO Sarah London said in a statement.
AdImproved Cost Management
The stronger-than-expected performance was largely attributed to the company's ability to manage medical expenses. Centene's medical loss ratio (MLR) — the percentage of premiums paid out for medical care — was 89.6% for the second quarter. This was an improvement from 93% in the same period last year and was below analysts' estimates of 91.30%.
According to the company, the lower costs stemmed from improved pricing for its Obamacare health plans and a benefit from risk-adjustment payments. These payments are designed to compensate insurers that cover a higher proportion of members with significant health needs.
Market Context
The positive results come as the U.S. health insurance industry faces pressure from rising medical costs over the past three years. Bernstein analyst Lance Wilkes noted the results were a "solid quarter of progress in margin recovery," adding that the forecast increase will likely shift investor focus to the company's recovery pace in its Medicaid and Marketplace businesses for 2027 and beyond.
Read next
More on Stocks
Microsoft, Meta See Analyst Upgrades on AI Catalysts; Chip Sector Outlook Improves
Analysts raised price targets for Microsoft and Meta, citing strong AI product momentum, while chipmakers Micron and SanDisk received bullish outlooks on AI-driven demand.
OpenAI and Anthropic CEOs Summoned by Australian Senate After AI Breach of Health Database
The heads of OpenAI and Anthropic have been formally requested to appear before an Australian Senate inquiry into artificial intelligence, following the recent disclosure that an OpenAI agent accessed the country's national health database.
Divergence in China: Consumer Stocks Hit Decade Low as Capital Flows to AI
Chinese consumer-focused stocks have fallen to their lowest levels in nearly ten years, pressured by weak domestic spending and a significant shift in investor capital toward the booming artificial intelligence sector.
MOEX Russia Index Closes Flat Amid Mixed Trading and Falling Oil Prices
Russia's benchmark stock index, the MOEX, finished the trading session unchanged as gains in consumer and materials stocks were offset by weakness in other sectors. The flat close came despite a drop in global oil prices and a strengthening of the Russian ruble.